Literature DB >> 6159256

Morbidity of acute pancreatitis: the effect of aprotinin and glucagon.

.   

Abstract

In a double-blind, randomised trial, neither aprotinin nor glucagon given in relatively high doses for five days influenced the rate of recovery or incidence of complications in 257 patients with acute pancreatitis.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6159256      PMCID： PMC1419604          DOI： 10.1136/gut.21.4.334

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  4 in total

1.  Proceedings: Effect of glucagon on pain in acute pancreatitis.

Authors:  T A Waterworth; P G Bevan
Journal:  Ann R Coll Surg Engl       Date:  1976-07       Impact factor: 1.891

2.  A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis.

Authors:  C W Imrie; I S Benjamin; J C Ferguson; A J McKay; I Mackenzie; J O'Neill; L H Blumgart
Journal:  Br J Surg       Date:  1978-05       Impact factor: 6.939

3.  Glucagon therapy in acute pancreatitis.

Authors:  J R Condon; M Knight; J L Day
Journal:  Br J Surg       Date:  1973-07       Impact factor: 6.939

4.  Glucagon vs anticholinergics in the treatment of acute pancreatitis. A double-blind controlled trial.

Authors:  V Gilsanz; C P Oteyza; J L Rebollar
Journal:  Arch Intern Med       Date:  1978-04
  4 in total
  14 in total

Review 1.  Current therapeutic strategies in severe acute pancreatitis.

Authors:  M S Reynaert; T Dugernier; P J Kestens
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure.

Authors:  F Fiedler; G Jauernig; V Keim; A Richter; H J Bender
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

3.  High-dose intraperitoneal aprotinin treatment of acute severe pancreatitis: a double-blind randomized multi-center trial.

Authors:  R Berling; S Genell; K Ohlsson
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

4.  Abdominal Physical Signs of Inspection and Medical Eponyms.

Authors:  Vaibhav Rastogi; Devina Singh; Halil Tekiner; Fan Ye; Joseph J Mazza; Steven H Yale
Journal:  Clin Med Res       Date:  2019-07-15

5.  Effects of high-dose intraperitoneal aprotinin treatment on complement activation and acute phase response in acute severe pancreatitis.

Authors:  R Berling; K Ohlsson
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

Review 6.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

7.  Drug Therapy for Acute Pancreatitis.

Authors:  Yan Bi; Tegpal Atwal; Santhi Swaroop Vege
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

Review 8.  [Acute pancreatitis].

Authors:  S Wagner; H Lübbers; R Mahlke; C H Müller; P G Lankisch
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

9.  Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double-blind multicenter study.

Authors:  P Pederzoli; G Cavallini; M Falconi; C Bassi
Journal:  Int J Pancreatol       Date:  1993-10

Review 10.  Pharmacological approach to acute pancreatitis.

Authors:  Ulrich-Christian Bang; Synne Semb; Camilla Nojgaard; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.